Alpha-1-antitrypsin aerosolised augmentation abrogates neutrophil elastase-induced expression of cathepsin B and matrix metalloprotease 2 in vivo and in vitro

Geraghty, P.; Rogan, M. P.; Greene, C. M.; Brantly, M. L.; O'Neill, S. J.; Taggart, C. C.; McElvaney, N. G.
July 2008
Thorax;Jul2008, Vol. 63 Issue 7, p621
Academic Journal
Background: Neutrophil elastase (NE) activity is increased in lung diseases such as α1-antitrypsin (A1AT) deficiency and pneumonia. It has recently been shown to induce expression of cathepsin B and matrix metalloprotease 2 (MMP-2) in vitro and in a mouse model. It is postulated that increased cathepsin B and MMP-2 in acute and chronic lung diseases result from high levels of extracellular NE and that expression of these proteases could be inhibited by A1AT augmentation therapy. Methods: Cathepsin and MMP activities were assessed in bronchoalveolar lavage (BAL) fluid from patients with A1AT deficiency, pneumonia and control subjects. Macrophages were exposed to BAL fluid rich in free NE from patients with pneumonia following pretreatment with A1AT. MMP-2, cathepsin B, secretory leucoprotease inhibitor (SLPI) and lactoferrin levels were determined in BAL fluid from A1AT-deficient patients before and after aerosolisation of A1AT. Results: BAL fluid from both patients with pneumonia and those with A1AT deficiency containing free NE had increased cathepsin B and MMP-2 activities compared with BAL fluid from healthy volunteers. The addition of A1AT to BAL fluid from patients with pneumonia greatly reduced NE-induced cathepsin B and MMP-2 expression in macrophages in vitro. A1AT augmentation therapy to A1AT-deficient individuals also reduced cathepsin B and MMP-2 activity in BAL fluid in vivo. Furthermore, A1AT-deficient patients had higher levels of SLPI and lactoferrin after A1AT augmentation therapy. Conclusion: These findings suggest a novel role for A1AT inhibition of NE-induced upregulation of MMP and cathepsin expression both in vitro and in vivo.


Related Articles

  • Outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency presenting with liver involvement. Hadzic, Nedim; Francavilla, Ruggiero; Chambers, Susan M.; Castellaneta, Stefania; Portmann, Bernard; Mieli-Vergani, Giorgina // European Journal of Pediatrics;Apr2005, Vol. 164 Issue 4, p250 

    Examines the outcome of PiSS and PiSZ alpha-1-antitrypsin deficiency (A1ATD) presenting with liver involvement in children. Charcteristics of A1ATD; Putative pathogenic mechanism for the liver disease in PiZZ A1ATD; Subjects of the study.

  • α-1 Antitrypsin regulates human neutrophil chemotaxis induced by soluble immune complexes and IL-8. Bergin, David A.; Reeves, Emer P.; Meleady, Paula; Henry, Michael; McElvaney, Oliver J.; Carroll, Tomás P.; Condron, Claire; Chotirmall, Sanjay H.; Clynes, Martin; O'Neill, Shane J.; McElvaney, Noel G.; Carroll, Tomás P // Journal of Clinical Investigation;Dec2010, Vol. 120 Issue 12, p4236 

    Hereditary deficiency of the protein α-1 antitrypsin (AAT) causes a chronic lung disease in humans that is characterized by excessive mobilization of neutrophils into the lung. However, the reason for the increased neutrophil burden has not been fully elucidated. In this study we have...

  • University College London Collaboration Aims to Treat Alpha-1-Antitrypsin Deficiency (Case study). Lomas, David // International Labmate;Apr2014, Vol. 39 Issue 3, p52 

    The article presents a case study of treating Alpha-1 antitrypsin deficiency.

  • Therapeutic levels for α1-antitrypsin following intrapleural administration of a non-human primate serotype rh10 AAV vector expressing α1-antitrypsin  // Molecular Therapy;May2004 Supplement 1, Vol. 9, p128 

    An abstract of the article "Therapeutic Levels for α1-Antitrypsin Following Intrapleural Administration of a Non- Human Primate Serotype rh10 AAV Vector Expressing α1-Antitrypsin," by Bishnu P. De, Nabil Wasif, Neil R. Hackett, Guangping Gao, and James M. Wilson is presented.

  • Tobacco Smoking and Other Factors in Relation to Serum Alpha-1 -Antitrypsin. Petridou, E.; Chapuis-Cellier, C.; Roukas, K.; Lan, S.-J.; Tzonou, A.; Trichopoulos, D. // Human Biology;jun93, Vol. 65 Issue 3, p425 

    Serum levels of alpha-1-antitrypsin were measured by radial immunodiffusion, and phenotypes were determined by electrofocusing in acrylamide gel in 160 subjects who were used as controls in a case-control study of hepatocellular carcinoma (HCC). The results were studied in relation to age, sex,...

  • α1-Antitrypsin: more than just deficiency. Stockley, R. A. // Thorax;May2004, Vol. 59 Issue 5, p363 

    Abnormal levels of α 1-antitrypsin represent a syndrome of clinical disease entities, some relating to a deficiency while others reflect an overload. With growing interest in the genetic nature of diseases and the clinical disorders associated with antitrypsin abnormalities, many countries...

  • &alph;1-Antitrypsin deficiency 3: Clinical manifestations and natural history. Needham, M.; Stockley, R. A. // Thorax;May2004, Vol. 59 Issue 5, p441 

    It has been long recognized that α 1 antitrypsin (AAT) deficiency is associated with an increase in clinical symptoms and diseases in several systems. Patients may be diagnosed with AAT deficiency after presentation with symptoms or through family screening of an index case. Close association...

  • α-1 Antitrypsin Deficiency and Splenic Artery Aneurysm Rupture: An Association? Gaglio, Paul J.; Regenstein, F.; Slakey, D.; Cheng, S.; Takiff, H.; Rinker, R.; Dick, D.; Thung, S. N. // American Journal of Gastroenterology;Jun2000, Vol. 95 Issue 6, p1531 

    OBJECTIVE: Theoretically, patients with alpha 1-antitrypsin deficiency may be vulnerable to the development of splenic artery aneurysms. α-1 antitrypsin deficiency can induce cirrhosis with portal hypertension, and resulting protease-antiprotease imbalances may exaggerate arterial wall...

  • © DISTRIBUTION OF THE SIX χ1-ANTITRYPSIN (PI) SUBTYPES FROM A SAMPLE OF BLOOD DONORS. Mulley, John C. // Australian Journal of Experimental Biology & Medical Science;Aug1980, Vol. 58 Issue 4, p409 

    Investigates the distribution of alpha 1-antitrypsin subtypes from blood donors in Adelaide, South Australia. Classification of phenotypes; Proportion of heterozygotes; Genetic variation in alpha 1-antitrypsin.


Read the Article


Sign out of this library

Other Topics